Synergistic effect study on the co-delivery of paclitaxel and SiRNA targeting STMN1 based on MPDA nanoparticles in the therapy of ovarian cancer
Our nanoparticle offers an innovative strategy for the concurrent therapy and monitoring of ovarian cancer, enhancing therapeutic efficacy and diagnostic precision.
Authors
- Yangyang Han (ORCID: https://orcid.org/0000-0002-4913-1111)
- Ling Wen (ORCID: https://orcid.org/0000-0003-1024-380X)
- Xueqian Qian
- Weikai Li (ORCID: https://orcid.org/0000-0002-8711-1904)
- Xiaotong Wang (ORCID: https://orcid.org/0000-0002-8821-397X)
- Guangxin Duan
- Manlin Li (ORCID: https://orcid.org/0000-0002-4763-8840)
- Yaning Zhang (ORCID: https://orcid.org/0009-0007-5753-3835)
- Yi Yuan (ORCID: https://orcid.org/0000-0002-9726-0305)
Institutions
- Weifang Medical University (CN)
- Soochow University (TW)
- Soochow University (CN)
- Second Affiliated Hospital of Soochow University (CN)
- First Affiliated Hospital of Soochow University (CN)
Publication Details
- Journal
- Journal of Nanobiotechnology
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1186/s12951-025-03827-8
- Citations
- 1
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.60
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province